hematopoetic stem cells and T-Cells are being manipulated by ddRNAi in Calimmune's trial, hence the funding from CIRM in the first place.
I'm not saying that they will mention Calimmune, but as it is one of the most advanced through the clinic of any program they are funding, I bet they will.